Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-16-087771
Filing Date
2016-01-04
Accepted
2016-01-04 17:06:11
Documents
1
Period of Report
2016-01-01

Document Format Files

Seq Description Document Type Size
1 3 a3.html 3  
1 3 a3.xml 3 6259
  Complete submission text file 0001104659-16-087771.txt   7886
Mailing Address C/O ANTHERA PHARMACEUTICALS, INC. 25801 INDUSTRIAL BOULEVARD, SUITE B HAYWARD CA 94545
Business Address
Thompson Peter A. (Reporting) CIK: 0001357522 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37368 | Film No.: 161318982

Mailing Address 101 PARK DRIVE MILTON PARK ABINGDON, OXFORDSHIRE X0 OX14 4RY
Business Address 101 PARK DRIVE MILTON PARK ABINGDON, OXFORDSHIRE X0 OX14 4RY 44 1235 430000
Adaptimmune Therapeutics PLC (Issuer) CIK: 0001621227 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 0630
SIC: 2836 Biological Products, (No Diagnostic Substances)